CapitolRadar tracks every publicly disclosed BAX trade by US congress members and corporate insiders: 60 disclosed trades (34 buys, 26 sells) by 4 tracked traders, from 2019-02-27 to 2026-05-01. Updated daily from official filings.
Want a ping when Congress buys BAX? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Baxter International Inc. (BAX) — Healthcare · Medical - Instruments & Supplies, market cap about $12.9B.
CapitolRadar analysis
49 tracked BAX trades, all tied to one trader
49 transactions in Baxter International Inc. were tracked from April 13, 2022 through May 1, 2026: 31 buys and 18 sells. Buys therefore represented 63.3% of the recorded activity, compared with 36.7% for sells. However, the entire sample comes from just one distinct trader, Ro Khanna, so the buy-heavy split does not indicate broad participation across multiple congressional filers. Khanna accounted for all 31 buys, with the latest dated May 1, 2026.
16 trades in 2023 Q3 formed the largest reported cluster
2023 Q3 recorded 16 trades, including 14 buys, making it the most active quarter in the supplied breakdown and the quarter with the strongest buy concentration. Other reported periods were more mixed: 2023 Q2 had six trades with three buys, 2023 Q4 had four with two buys, and 2025 Q3 had six with three buys. The smaller periods included 2026 Q2 with one buy, 2024 Q1 with one sell, 2023 Q1 with three buys among four trades, and 2022 Q4 with one buy among three trades.
The listed quarterly figures account for 41 of the 49 total tracked transactions, so eight trades are not represented in the supplied quarter-by-quarter detail. No conclusion about their timing or direction can be drawn from this dataset.
Six overlapping tickers, but only one shared buyer
One buyer in this BAX sample also bought each of AJG, BAC, CDNS, DASH, FDX and IBM. Because there is only one distinct BAX trader, these overlaps describe that individual’s disclosed activity rather than a recurring pattern shared by several buyers.
Congressional disclosures may be filed up to 45 days after a transaction, so reported activity is not necessarily contemporaneous. Disclosed transaction amounts are generally presented as ranges and should be treated as estimates. The one-trader sample is especially small, limiting any broader inference about sentiment toward Baxter or the Healthcare / Medical - Instruments & Supplies industry.
Analysis written from the tracked record on 2026-08-31; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q2 | 1 | 1 | 0 |
| 2026 Q1 | 2 | 2 | 0 |
| 2025 Q3 | 8 | 4 | 4 |
| 2024 Q1 | 1 | 0 | 1 |
| 2023 Q4 | 4 | 2 | 2 |
| 2023 Q3 | 16 | 14 | 2 |
| 2023 Q2 | 6 | 3 | 3 |
| 2023 Q1 | 4 | 3 | 1 |
Who is buying BAX?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 32 | 2026-05-01 | — |
| Michael McCaul | 2 | 2026-03-23 | — |
Disclosed trades in BAX
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-05-01 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-03-23 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2026-01-13 | Michael McCaul | buy | $50,001 - $100,000 | — |
| 2025-09-29 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-09-05 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-09-03 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-08-26 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-08-12 | Ro Khanna | sell | $1,000 - $15,000 | — |
| 2025-08-12 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-08-04 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-08-04 | Ro Khanna | buy | $1,000 - $15,000 | — |
| 2024-01-08 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-10-31 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-10-20 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-17 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-02 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-09-28 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-09-27 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-09-06 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-08-21 | Ro Khanna | buy | $1,001 - $15,000 | — |
These buyers also bought
Other stocks the tracked buyers of BAX disclosed buying in the last six months: MA (2) · META (2) · TER (2) · P (2) · WDAY (2) · INTU (2).
About Baxter International Inc.
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compo…
Frequently asked questions
Which politicians bought BAX most?
Ro Khanna leads with 32 disclosed buys, followed by Michael McCaul.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.